{"id":"W2913215587","doi":"10.3389/fimmu.2019.00040","title":"Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies","year":2019,"lang":"en","type":"article","venue":"Frontiers in Immunology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"University of California, Irvine; University of Alberta","keywords":"Tolerability; Medicine; Adverse effect; Prospective cohort study; Antibody; Internal medicine; Pediatrics; Anesthesia; Immunology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007407766,0.0004068901,0.001490719,0.0003124238,0.000102035,0.00001002581,0.0007193437,0.0004751653,0.0001015286],"category_scores_gemma":[0.00009083284,0.0002810371,0.0002169743,0.000566372,0.001542151,0.0001259377,0.0001149875,0.0005081976,0.00001773153],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002304677,"about_ca_system_score_gemma":0.0003038823,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009887893,"about_ca_topic_score_gemma":0.00003738356,"domain_scores_codex":[0.9963375,0.0007240362,0.001592113,0.0005900628,0.0001026195,0.0006537034],"domain_scores_gemma":[0.997764,0.0005650411,0.0005588246,0.001010595,0.00009283472,0.000008685209],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0150915,0.005036152,0.8269703,0.00005924153,0.0004437833,0.000005763392,0.008692871,0.00008577618,0.003284879,0.0002979462,0.00004284019,0.1399889],"study_design_scores_gemma":[0.01256558,0.005467759,0.9613239,0.00008345027,0.00006872848,0.00003135643,0.003775979,0.000005177643,0.0004963082,0.0001619326,0.01569771,0.0003221422],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9250305,0.071516,0.0001060631,0.00008474164,0.001173926,0.001174964,0.00004220679,0.0000204435,0.0008511072],"genre_scores_gemma":[0.9956717,0.003494825,0.0001916291,0.00005535442,0.000002314075,0.00001403418,0.0001737291,0.00002238223,0.0003740272],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1396668,"threshold_uncertainty_score":0.9999642,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006349287908015364,"score_gpt":0.220113540752536,"score_spread":0.2137642528445206,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}